| 000 | 01810 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513201658.0 | ||
| 264 | 0 | _c20000330 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a0168-3659 | ||
| 024 | 7 |
_a10.1016/s0168-3659(99)00146-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYe, Q | |
| 245 | 0 | 0 |
_aDepoFoam technology: a vehicle for controlled delivery of protein and peptide drugs. _h[electronic resource] |
| 260 |
_bJournal of controlled release : official journal of the Controlled Release Society _cFeb 2000 |
||
| 300 |
_a155-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Proteins _xanalysis |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aDelayed-Action Preparations _xpharmacokinetics |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 |
_aEnkephalins _xadministration & dosage |
| 650 | 0 | 4 |
_aEscherichia coli _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 |
_aLeuprolide _xadministration & dosage |
| 650 | 0 | 4 |
_aLiposomes _xchemistry |
| 650 | 0 | 4 | _aMicroscopy, Confocal |
| 650 | 0 | 4 |
_aOctreotide _xadministration & dosage |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 |
_aPeptides _xadministration & dosage |
| 650 | 0 | 4 |
_aProteins _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aAsherman, J | |
| 700 | 1 | _aStevenson, M | |
| 700 | 1 | _aBrownson, E | |
| 700 | 1 | _aKatre, N V | |
| 773 | 0 |
_tJournal of controlled release : official journal of the Controlled Release Society _gvol. 64 _gno. 1-3 _gp. 155-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0168-3659(99)00146-7 _zAvailable from publisher's website |
| 999 |
_c10595923 _d10595923 |
||